The Real Stock Market Wealth Is Made... At 3pm!
Steady gains in 18 hours?? Pro traders call this the 3PM “burn window”… ACCESS NOW!
Continue Reading

EPIX Insider Trading (ESSA Pharma)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $1,539,000.00
Insider Selling (Last 12 Months): $0.00

ESSA Pharma Insider Trading History Chart

ESSA Pharma Share Price & Price History

▲ +0.07 (0.25%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
Finance PhD: Move Your Money Before April 30th
The clock just starting ticking on the biggest financial event in 20 years. The next few weeks could decide your wealth in 2021.
See what you should do now

ESSA Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/22/2021Franklin M BergerDirectorBuy57,000$27.00$1,539,000.00957,244  
See Full Table

SEC Filings (Institutional Ownership Changes) for ESSA Pharma (NASDAQ:EPIX)

63.37% of ESSA Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ESSA Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/16/2021Orbimed Advisors LLC460,500$5.49M0.0%-60.9%1.436%
2/16/2021Silverarc Capital Management LLC322,917$3.85M2.2%N/A1.007%
2/16/2021Morgan Stanley466,714$5.57M0.0%+34.6%1.456%
2/16/2021Pura Vida Investments LLC110,149$1.31M0.0%+450.7%0.344%
2/16/2021Avidity Partners Management LP2,558,000$30.52M1.0%+22.5%7.978%
2/16/2021Janus Henderson Group PLC509,095$6M0.0%+7.0%1.588%
2/16/2021Prelude Capital Management LLC23,304$0.28M0.0%+86.4%0.073%
2/12/2021Opaleye Management Inc.284,050$3.39M0.4%+4.7%0.886%
2/10/2021Renaissance Technologies LLC62,803$0.75M0.0%-31.6%0.196%
1/19/2021Rhenman & Partners Asset Management AB156,700$1.87M0.2%N/A0.489%
11/16/2020Blackstone Group Inc3,573,053$24.65M0.1%+5.9%11.144%
11/16/2020Caxton Corp26,590$0.18M0.2%N/A0.083%
11/13/2020Morgan Stanley346,819$2.39M0.0%+175.5%1.082%
11/13/2020Vivo Capital LLC1,516,865$10.47M0.6%N/A4.731%
11/12/2020JPMorgan Chase & Co.4,927$34K0.0%N/A0.015%
11/12/2020Sphera Funds Management LTD.250,000$1.73M0.2%N/A0.780%
8/17/2020Omega Fund Management LLC1,497,448$9.28M2.5%-11.4%7.184%
8/14/2020Opaleye Management Inc.175,000$1.09M0.2%N/A0.840%
8/14/2020BVF Inc. IL1,984,889$12.31M0.8%-18.0%9.523%
8/12/2020Commonwealth Equity Services LLC24,270$0.15M0.0%+15.5%0.116%
5/18/2020Advisor Group Holdings Inc.8,500$34K0.0%N/A0.041%
5/15/2020RA Capital Management L.P.959,300$3.84M0.1%-4.1%4.620%
5/15/2020Soleus Capital Management L.P.2,080,421$8.32M9.7%+27.3%10.020%
5/14/2020Janus Henderson Group PLC198,799$0.80M0.0%N/A0.958%
2/13/2020Renaissance Technologies LLC12,813$70K0.0%N/A0.062%
2/12/2020Advisor Group Inc.8,500$47K0.0%N/A0.041%
11/27/2019Orbimed Advisors LLC1,471,853$4.96M0.1%N/A10.026%
11/27/2019Eventide Asset Management LLC2,010,169$6.44M0.2%+45.1%13.692%
10/30/2019Commonwealth Equity Services LLC11,500$38K0.0%N/A0.078%
8/14/2018DRW Securities LLC33,857$0.13M0.0%N/A0.586%
8/2/2018Omega Fund Management LLC1,084,848$4.12M3.0%N/A18.769%
8/3/2017Clarus Ventures LLC2,121,212$1.17M1.1%No Change7.290%
7/26/2017Omega Fund Management LLC1,696,969$0.93M0.6%No Change5.832%
Data available starting January 2016

See Full Table
ESSA Pharma logo
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.
Read More

Today's Range

Now: $28.37

50 Day Range

MA: $29.03

52 Week Range

Now: $28.37


108,396 shs

Average Volume

369,655 shs

Market Capitalization

$958.34 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of ESSA Pharma?

ESSA Pharma's top insider investors include:
  1. Franklin M Berger (Director)
The Real Stock Market Wealth Is Made... At 3pm!
Steady gains in 18 hours?? Pro traders call this the 3PM “burn window”… ACCESS NOW!
Continue Reading